Patents by Inventor Belen Ybarrondo

Belen Ybarrondo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for predicting response of triple-negative breast cancer to therapy
    Patent number: 10697967
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells such as triple-negative metastatic breast tumor cells. Information on the expression and/or activation levels of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: June 30, 2020
    Assignee: Société des Produits Nestlé S.A.
    Inventors: Xinjun Liu, Phillip Kim, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • Drug selection for gastric cancer therapy using antibody-based arrays
    Patent number: 10473640
    Abstract: The present invention provides methods for selecting a suitable anticancer therapy, and for identifying and predicting response for the treatment of a gastric cancer.
    Type: Grant
    Filed: January 26, 2011
    Date of Patent: November 12, 2019
    Assignee: Société des Produits Nestlé S.A.
    Inventors: Sharat Singh, Phillip Kim, Xinjun Liu, Belen Ybarrondo
  • METHODS FOR PREDICTING RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER TO THERAPY
    Publication number: 20170227542
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells such as triple-negative metastatic breast tumor cells. Information on the expression and/or activation levels of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: September 20, 2016
    Publication date: August 10, 2017
    Applicant: DiaTech Holdings, Inc.
    Inventors: Xinjun Liu, Phillip Kim, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy
    Patent number: 9726669
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: August 8, 2017
    Assignee: PIERIAN HOLDINGS, INC.
    Inventors: Phillip Kim, Xinjun Liu, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • Methods for predicting response of triple-negative breast cancer to therapy
    Patent number: 9488654
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells such as triple-negative metastatic breast tumor cells. Information on the expression and/or activation levels of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Grant
    Filed: July 10, 2012
    Date of Patent: November 8, 2016
    Assignee: DIATECH HOLDINGS, INC.
    Inventors: Xinjun Liu, Phillip Kim, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • DRUG SELECTION FOR GASTRIC CANCER THERAPY USING ANTIBODY-BASED ARRAYS
    Publication number: 20130237436
    Abstract: The present invention provides methods for selecting a suitable anticancer therapy, and for identifying and predicting response for the treatment of a gastric cancer.
    Type: Application
    Filed: January 26, 2011
    Publication date: September 12, 2013
    Applicant: Prometheus Laboratories Inc.
    Inventors: Sharat Singh, Phillip Kim, Xinjun Liu, Belen Ybarrondo
  • METHODS FOR PREDICTING RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER TO THERAPY
    Publication number: 20130012407
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells such as triple-negative metastatic breast tumor cells. Information on the expression and/or activation levels of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: July 10, 2012
    Publication date: January 10, 2013
    Applicant: Nestec S.A.
    Inventors: Xinjun Liu, Phillip Kim, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • DRUG SELECTION FOR CANCER THERAPY BY PROFILING SIGNAL TRANSDUCTION PROTEINS IN ASCITES OR PLEURAL EFFLUX SAMPLES
    Publication number: 20120270745
    Abstract: The present invention provides methods for selecting a suitable anticancer therapy and for identifying and predicting response for the treatment of a gastric cancer by determining the expression level and/or activation level of one or more analytes in a cell such as a cancer cell from an ascites sample. The present invention also provides methods for selecting a suitable anticancer therapy and for identifying and predicting response for the treatment of a lung cancer such as a non-small cell lung cancer by determining the expression level and/or activation level of one or more analytes in a cell such as a cancer cell from a pleural efflux sample.
    Type: Application
    Filed: January 19, 2012
    Publication date: October 25, 2012
    Applicant: Prometheus Laboratories Inc.
    Inventors: Sharat Singh, Phillip Kim, Xinjun Liu, Belen Ybarrondo, Limin Liu
  • DRUG SELECTION FOR GASTRIC CANCER THERAPY USING ANTIBODY-BASED ARRAYS
    Publication number: 20110281748
    Abstract: The present invention provides methods for selecting a suitable anticancer therapy, and for identifying and predicting response for the treatment of a gastric cancer.
    Type: Application
    Filed: January 26, 2011
    Publication date: November 17, 2011
    Applicant: Prometheus Laboratories Inc.
    Inventors: Sharat Singh, Phillip Kim, Xinjun Liu, Belen Ybarrondo
  • BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY
    Publication number: 20110071042
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: August 10, 2010
    Publication date: March 24, 2011
    Applicant: Prometheus Laboratories Inc.
    Inventors: Phillip Kim, Xinjun Liu, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh